Market revenue in 2023 | USD 319.2 million |
Market revenue in 2030 | USD 400.0 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.86% in 2023. Horizon Databook has segmented the Latin America attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
ADHD is one of the most prevalent disorders in Latin America. The treatment rate in this region is much lower than developed economies. Therefore, there is a need to increase awareness about the available number of treatment solutions to adopt safe and effective medication that would boost market growth.
Moreover, increase in healthcare expenditure has positively impacted the demand for ADHD drugs by increasing healthcare spending. For instance, as of October 2020, the Brazilian government spent over BRL 120 billion (approximately USD 22 billion) on healthcare. Brazil is expected to dominate the market in Latin America, followed by Mexico and Argentina, which are also boosting their investments in the ADHD market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America attention deficit hyperactivity disorder market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account